|
Drug Enhancement Company of America |
|
Joel Ivers Biography |
|
Significant Acquisitions, Developments and Mergers |
|
Mr. Ivers has participated in the following acquisitions, developments, and mergers:
Original team founding Recombinant Biocatalysis (which became Diversa Corporation, and recently Verenium Corporation) - 1994
Team member of the merger of Exemplar Systems and DARCA, Inc. to form Elumen Solutions - 1998
Team member of the acquisition of Elumen Solutions by Computer Task Group (CTG), Inc. - 1999
Team leader of the acquisition of International Clinical Evaluations by Hill Top Research, Inc. - 2004
Team member (one of three) for the sale of Hill Top Research, Inc. to DW Healthcare Partners - 2005 |
|
Joel Ivers has over 25 years of experience in diagnostics, biotechnology, information technology, clinical research, and pharmaceuticals where he has developed extensive strategic marketing, licensing, business development, operations, and senior management expertise.
Joel began his career in 1979 as a high school chemistry teacher in Cincinnati and then moved through various sales and management positions at Ortho Diagnostic Systems, a division of Johnson and Johnson. In 1990, Joel launched and developed the market for The Big Blue® Transgenic Mouse Mutagenesis Assay System worldwide and managed a national sales force at Stratagene, where he was VP Mutagenesis Marketing and North American Sales. Joel later became the VP Marketing and one of the founders of Diversa (now known as Verenium Corporation), an enzyme discovery biotechnology company, currently listed on the NASDAQ. In 1997, Joel joined a health care IT firm which was later acquired by Computer Task Group (CTG), a publicly held IT consulting firm. Joel served as Chief Marketing Officer for CTG where he formed and led a global marketing organization. Joel joined Hill Top Research in 2002 where he served as Chief Operation Officer and Chief Executive Officer.
Joel is a board member of BioStart, Cincinnati's biotechnology business incubator, and served as a member of the Bioscience Task Force for the state of Ohioís Business Roundtable working on A Prospectus for Achieving Success in the Third Frontier. Recently Joel was a speaker at the BioPharma in Ohio conference, and has served as an Adjunct Professor at the University of Cincinnati School of Pharmacy.
Joel earned a Masters Degree in Genetics and Molecular Biology from Indiana University, Bloomington, and a Bachelors Degree in Chemistry from The University of Redlands in Redlands, California. |